Roadman Investments Announces Anton Gomez-Escolar, Psychopharmacology Specialist to Join Advisory Board

ID: 1552142
recent pressrelease next pressrelease

(businesspress24) - September 12,2019 - VANCOUVER, British Columbia - Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD)(OTC: RMANF) (Roadman Investments or the Company) is pleased to announce that Anton Gomez-Escolar has joined the companys strategic advisory board.

Mr. Gomez-Escolar has a Masters in Psychopharmacology from Spains largest university Complutense University of Madrid, including a Master Thesis on the topic of "Psychedelics in psychotherapy for the treatment of depression and addiction", a Masters in International Relations by Griffith University from Australia, and many other diplomas including a certificate of Design and Interpretation of Clinical Trials from John Hopkins School of Public Health, a certificate in Drug Discovery, Development & Commercialization from UCSD and a certificate in Drug Use, Policy and Health from the University of Geneva

Mr. Gomez-Escolar has worked in harm reduction offering drug education, drug checking and emergency trip-sitting services in music festivals and other settings, with many organizations including Energy Control (from ABD Welfare and Development Association, Spain), Kosmicare (Portugal), Check!n (Portugal), Safen Sound (Belgium) and Zendo project (from theMultidisciplinary Association for Psychedelic Studies MAPS, USA) . This experience in neuropharmacology and safety has helped him to provide harm reduction education and manage psychedelic emergencies on the field, increasing his practical knowledge of psychedelic compounds and their effects, risks and potential.

In addition to co-founding the Psychedelic Society of Madrid and Lisbon, he has taken part in several conferences on the topic of clinical psychedelic research and other psychopharmacological topics, including Psychedelic Science (San Francisco), Interdisciplinary Conference on Psychedelics Research (Amsterdam), Breaking Convention (London), World Ayahuasca Conference (Spain), Harm Reduction International (Porto), Lisbon Addictions Conference (Lisbon), Altered States of Consciousness (Madrid), Club Health (Amsterdam) and NIGHTS (Berlin).

Most recently, Mr. Gomez-Escolar worked at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the official European Union drugs information agency, based in Lisbon, where, among many other responsibilities,he developed a comprehensive e-learning tool to provide training in different drug-related topics for the European Union National Focal Points and other stakeholders, and participated in the 2018 Drug Summer School organised by ISCTE University and the EMCDDA.

His technical understanding of neurobiology, psychopharmacology, drug safety and clinical trial development will allow Roadman Investments to better evaluate potential investments in biotech firms as well as help the company provide advisory services to future investees or partners that need this expertise.

Anton will join Roadmans Health and Wellness committee and act in an advisory capacity. Mr. Gomez-Escolars anticipated responsibilities include identifying new investing opportunities within the alternative health space, advising Roadman during technical due diligence, conducting media interviews and attending industry conferences.

Luke Montaine, Chief Executive Officer and a Director of Roadman Investments "Adding Psychopharmacology specialist like Anton Gomez-Escolar will allow us to make more informed investment decisions as well as it will provide the company with the technical expertise needed for us to provide tremendous value to the companies that we invest in.

About Roadman Investments
Roadman Investments Inc. is engaged in the business of incubating and working with start up entities in with a view to generate capital and generate returns for its shareholders via the tactical deployment of capital across the resource, agricultural, financial services, technology and health and wellness verticals.

For further information, please contact:

Media Contact:
Nikolai Vassev
+1 (778) 772-1751

Roadman Investments
Suite 810 - 789 West Pender Street
Vancouver, British Columbia
V6C 1H2
(604) 687-2038

Learn more about Roadman by visiting our website at:

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements - This news release contains certain forward-looking statements, including statements regarding the business of the Company. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward looking statements, oral or written, made by itself or on its behalf except as required by law.

More information:

Keywords (optional):

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 09/12/2019 - 08:32
Language: English
News-ID 1552142
Character count: 5436
Firma: Roadman Investments Corp.
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 638


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 88

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.